Welcome to our dedicated page for Astronova SEC filings (Ticker: ALOT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AstroNova, Inc. filings document an operating company with common stock listed on the Nasdaq Global Market under ALOT. Recent reports include 8-K disclosures for quarterly and annual operating results, amendments to its credit agreement, compensation award terms and other material events tied to its Product Identification and Aerospace businesses.
Proxy and shareholder-meeting filings describe board elections, director nominations, executive compensation votes, auditor ratification and governance matters. The filing record also covers capital structure details such as common stock par value, financial obligations under lending arrangements, exhibit disclosures attached to earnings releases and credit agreement amendments, and formal records related to shareholder proposals and annual meeting procedures.
AstroNova, Inc. Chief Technology Officer Michael J. Natalizia reported a series of compensation-related equity transactions, mainly the vesting and settlement of restricted stock units into common stock. On multiple dates from March 21 to April 17, he exercised derivative awards to acquire an aggregate of 2,427 shares of common stock, reflected as zero exercise price entries.
In connection with these vestings, a total of 894 shares of common stock were disposed of as tax-withholding dispositions, meaning shares were withheld to cover tax obligations rather than sold in the open market. After these transactions, he directly owned about 47,349.3445 shares of AstroNova common stock. Footnotes indicate that certain restricted stock units have fully vested and settled, while other remaining units are scheduled to vest in 2027 under stated annual vesting schedules.
AstroNova, Inc. Vice President Thomas Wayne Carll reported routine equity compensation activity. On several dates between March 21 and April 17, 2026, he exercised restricted stock units (RSUs) into a total of 2,321 shares of common stock, at a stated exercise price of $0.00 per share.
To cover related tax obligations, 855 common shares were disposed of through tax-withholding transactions rather than open-market sales. After these exercises and withholdings, he directly owned 33,621 shares of AstroNova common stock. Footnotes state that some RSUs have fully vested and settled, while remaining RSUs are scheduled to vest in 2027.
AstroNova, Inc. Chief Financial Officer Thomas D. DeByle reported compensation-related equity transactions in common stock and restricted stock units on April 14, 2026. He acquired 6,838 shares of common stock through derivative exercises and had 2,513 shares withheld to cover tax obligations, a non-market disposition method.
Following these transactions, he directly held 7,418.2084 shares of AstroNova common stock. He also held 6,886 restricted stock units, each representing a contingent right to receive one share of common stock, which are scheduled to vest in two equal annual installments beginning April 14, 2027.
AstroNova, Inc. updated the structure of certain executive incentive awards. On April 10, 2026, the company entered into Stock-Settled Performance Award Amendment Agreements with its President and CEO Jorik Ittmann, CFO Thomas DeByle, Senior VP–Aerospace Thomas Carll, and CTO Michael Natalizia.
The amendments allow the Human Capital and Compensation Committee to choose to settle these Stock Settled Performance Awards in cash instead of AstroNova common stock. All other terms of the existing performance awards remain unchanged.
AstroNova, Inc. files its annual report describing a two-segment business focused on Product Identification printers and supplies and Aerospace printers, networking gear and data acquisition systems. The company completed the MTEX New Solution acquisition in May 2024, expanding its mid‑to‑high volume packaging and labeling portfolio.
In April 2026 the board launched a review of strategic alternatives, which may include a sale, merger or other transactions, alongside continuing the existing plan. Backlog was $28.2 million at January 31, 2026, and international operations represented about 40% of revenue. Total debt was $37.7 million and cash and cash equivalents were $4.1 million.
The report highlights key risks, including reliance on contract manufacturers and single‑source suppliers, competition, goodwill impairment tied to MTEX, cybersecurity threats, evolving AI use, tariff and macroeconomic pressures, international regulatory exposure, and significant leverage under its Bank of America credit facilities. AstroNova employed 398 full-time staff as of January 31, 2026.
AstroNova, Inc. reported fiscal 2026 fourth-quarter revenue of $37.5 million, essentially flat year over year, as stronger Product Identification sales offset slightly lower Aerospace revenue. Quarterly gross margin slipped to 30.2%, and the company posted a net loss of $1.1 million, or $(0.15) per share, a much smaller loss than the prior year’s impairment-affected results.
For the full year, revenue was $150.5 million and net loss improved significantly to $2.4 million from $14.5 million, while Adjusted EBITDA rose to $12.7 million with an 8.4% margin. Operating cash flow reached $11.7 million, helping reduce debt to $37.6 million as of January 31, 2026.
Product ID segment revenue grew to $104.2 million, with aftermarket sales around 80% of the segment, while Aerospace delivered $46.3 million of revenue and a 21.1% operating margin. Management highlighted strong Aerospace bookings and backlogs in both segments, and noted that a major Aerospace royalty obligation expiring in the third quarter of fiscal 2027 is expected to add about $2 million to annual gross profit. For fiscal 2027, the company targets mid‑single‑digit revenue growth and higher adjusted EBITDA margin.
QUAIN MITCHELL I reported acquisition or exercise transactions in this Form 4 filing.
AstroNova director Mitchell I. Quain received a grant of 3,007 shares of Common Stock on April 9, 2026. The award is described as a restricted stock grant under the Amended and Restated Non-Employee Director Annual Compensation Program. Following this award, he holds 108,910 shares directly and 16,701 shares indirectly through a trust where he serves as trustee.
MICHAS ALEXIS P reported acquisition or exercise transactions in this Form 4 filing.
AstroNova director Alexis P. Michas received a grant of 3,053 shares of AstroNova common stock on April 9, 2026 as a restricted stock award under the Amended and Restated Non-Employee Director Annual Compensation Program. Following this award, he directly holds 29,319 common shares.
Separately, 535,203 AstroNova shares are held indirectly through Juniper Targeted Opportunity Fund, L.P., for which related entities managed by Mr. Michas serve as investment manager and general partner. He may be deemed to beneficially own those shares but disclaims beneficial ownership except for his pecuniary interest.
Schlaeppi Yvonne reported acquisition or exercise transactions in this Form 4 filing.
AstroNova director Yvonne Schlaeppi received a restricted stock award of 2,873 shares of Common Stock on April 9, 2026. The award was granted pursuant to the company’s Amended and Restated Non-Employee Director Annual Compensation Program and increased her direct holdings to 51,920.954 shares.
AstroNova, Inc. director receives stock award. Director Richard S. Warzala acquired 2,827 shares of AstroNova common stock on a grant/award basis at a price of $0.00 per share. The restricted stock award was made under the Amended and Restated Non-Employee Director Annual Compensation Program, bringing his direct holdings to 75,711 shares.